Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes

OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations by continuous glucose monitoring system (CGMS) in patients within newly diagnosed type 2 diabetes mellitus (T2DM) receiving continuous subcutaneous insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bing-li, Yin, Guo-ping, Li, Feng-fei, Hu, Yun, Wu, Jin-dan, Chen, Mao-yuan, Ye, Lei, Su, Xiao-fei, Ma, Jian-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892275/
https://www.ncbi.nlm.nih.gov/pubmed/29780415
http://dx.doi.org/10.1155/2018/2087960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892275/
https://www.ncbi.nlm.nih.gov/pubmed/29780415
http://dx.doi.org/10.1155/2018/2087960

Ejemplares similares